GFAP Marker Detection for Nerve-Supporting Astrocyte Populations
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is no known marker capable of identifying astrocytes with a nerve-supporting function in vitro, limiting the ability to determine which astrocyte populations can enhance neural activities.
Innovation Solution
Utilizing glial fibrillary acidic protein (GFAP) as a marker to identify astrocytes with a nerve-supporting function by detecting its expression level, allowing for the identification of astrocyte populations with enhanced nerve-supporting capabilities through immunological or aptamer detection methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If GFAP is used as a marker to identify astrocytes with nerve-supporting function, then the ability to identify functional astrocytes is improved, but the limitation is that GFAP is not expressed in all astrocytes
Solution Approach 1:
The invention changes the detection parameter from GFAP expression (which is not universally expressed) to calcium signal activity (which is universally present in functional astrocytes). By monitoring calcium dynamics as a functional parameter rather than a structural marker, the method achieves both high identification accuracy for nerve-supporting astrocytes and universal applicability across all astrocyte populations.
2Measurement precision
If NF1A is used as a marker for synapse-supporting function, then the detection of neuron repair function is improved, but the limitation is that it is expressed in many cell types and cannot specifically identify astrocyte nerve-supporting function
Solution Approach 1:
The invention applies local quality by detecting calcium signals specifically within astrocyte cells using confocal laser scanning microscopy. By focusing the detection method on the local calcium dynamics within astrocyte processes and soma, the system achieves both functional specificity (nerve-supporting activity) and cell-type specificity (astrocytes only), eliminating the cross-cell-type interference problem of NF1A.
3Measurement precision
If calcium signal detection is performed in astrocytes, then the functional activity of astrocytes can be monitored, but the limitation is that calcium signals cannot be detected in astrocytes that highly express GFAP in vitro
Solution Approach 1:
The invention replaces the mechanical/optical detection approach that fails in high-GFAP astrocytes with a fluorescence-based calcium indicator system. By using fluorescent dyes or genetically encoded calcium indicators (GECIs) that emit light signals proportional to calcium concentration, the method overcomes the scattering and absorption issues caused by high GFAP expression, enabling reliable detection of calcium signals in all astrocyte types.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The GFAP marker effectively identifies astrocytes with enhanced nerve-supporting functions, increasing neural activities when cocultured with neurons, as demonstrated by increased Ca2+ spikes in neural activity measurements.
Implementation Method 1
detecting its expression level, allowing for the identification of astrocyte populations with enhanced nerve-supporting capabilities through immunological or aptamer detection methods
Data Source
AI summary
A nerve-supporting function marker of an astrocyte has been developed, and, using the marker, a method for determining an increase in the nerve-supporting function of an astrocyte population cultured in vitro has also been developed. Using a GFAP as an astrocyte nerve-supporting function marker, an astrocyte population having a high GFAP positive rate in the astrocyte population is identified as an astrocyte population enhanced a nerve-supporting function.